Radimetrics™ Enterprise Platform version 2.5 aggregates data to help radiologists and administrators establish imaging protocols to comply with many current and proposed U.S. Joint Commission Standards for Diagnostic Imaging
Advanced contrast analytics provide tools that can help enable sites to improve imaging efficiency and drive quality improvements
Expanded data collection and analysis helps establish local dose standards to compare with external benchmarks
Ad Statistics
Times Displayed: 49670
Times Visited: 1409 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
Whippany, NJ - Bayer today unveiled version 2.5 of its Radimetrics™ Enterprise Platform at the 2014 Radiological Society of North America (RSNA) Scientific Assembly and Annual Meeting. The enhanced version has new features that can help radiologists and hospital administrators meet new 2015 U.S. Joint Commission Diagnostic Imaging Standards, providing information to help optimize radiation dose management and contrast dose analytics to advance image quality and patient care.
"With billions of diagnostic imaging procedures performed every year it's essential that patients aren't exposed to unnecessary levels of radiation," said Christiane Pering, Chief Medical Officer (CMO) and Head of Innovation, Bayer Medical Care. "We recognize the urgency to not only meet the new standards coming into effect next year, but to provide technology that keeps pace with the evolving needs of radiology."
The new software is a next generation upgrade of the platform, which was the first single tool to manage both radiation dose and contrast dose analytics in computed tomography (CT). New features include more advanced contrast dose analytics and new charts and data options to help identify repeat injections and issues associated with intravenous* administration.
Enhancements include the ability to align customers' various protocol names to standardized naming conventions from the RadLex® Playbook and further expand capabilities in mammography and general X-ray modalities, improving analytics and workflow efficiencies. Everything can be analyzed in line with external benchmarks, helping administrators further standardize protocols and identify training needs across all enterprise sites.
"The Radimetrics Enterprise Platform allows organizations to collect and analyze data across sites, creating large-scale, real-world dose registries that can help establish benchmarks and scanning parameters," said Dennis Durmis, Head of the Americas Region, Bayer's Radiology business. "We're now seeing how these data may help improve protocols, with registry information being presented at international scientific symposia."
